Haemonetics CorporationHAENYSE
Loading
Operating Expenses Over TimeStable
Percentile Rank87
3Y CAGR+3.5%
5Y CAGR+8.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+3.5%/yr
vs +8.7%/yr prior
5Y CAGR
+8.9%/yr
Recent deceleration
Acceleration
-5.2pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $517.80M | -7.0% |
| 2025 | $556.73M | +1.8% |
| 2024 | $547.03M | +17.2% |
| 2023 | $466.84M | +3.7% |
| 2022 | $450.02M | +32.9% |
| 2021 | $338.70M | -11.9% |
| 2020 | $384.47M | +15.1% |
| 2019 | $333.99M | -6.1% |
| 2018 | $355.75M | -10.6% |
| 2017 | $397.88M | - |